At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 188 enrolled
Drug / intervention
Refresh Optive® Gel Drops +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
In Brief
A Phase 3 clinical trial evaluating Refresh Optive® Gel Drops and REFRESH LIQUIGEL® for Dry Eye Syndromes. Completed, enrolled 188 participants across 10 sites.
Detailed Summary
This study will evaluate the safety and efficacy o fRefresh Optive® Gel Drops in patients with dry eye disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 2014
Enrollment StartNov 2014
Primary CompletionMar 2015
TodayJul 2026
First PostedOct 31, 2014
Enrollment StartNov 13, 2014
Primary CompletionMar 16, 2015
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 11.7 years ago
Interventions
Refresh Optive® Gel Dropsdrug
Refresh Optive® Gel Drops; 1-2 drops in each eye as needed at least 2 times daily for 30 days.
REFRESH LIQUIGEL®drug
REFRESH LIQUIGEL®; 1-2 drops in each eye as needed at least 2 times daily for 30 days.